Pneumococcal immunization with conjugate vaccines - are 10-valent and 13-valent vaccines similar?

被引：0
|
作者：
Vyse, Andrew [1 ]
Theilacker, Christian [2 ]
Sings, Heather [2 ]
Fletcher, Mark [3 ]
机构：
[1] Pfizer Ltd, Vaccines Med, Surrey, England
[2] Pfizer Inc, Vaccines Med Dev & Sci Clin Affairs, Collegeville, PA 19426 USA
[3] Pfizer Inc, Emerging Markets Med, Paris, France
来源：
FUTURE MICROBIOLOGY | 2020年 / 15卷 / 08期
关键词：
differentiation; immunogenicity; invasive pneumococcal disease; PCV10; PCV13; pneumococcal disease; DISEASE;
D O I：
10.2217/fmb-2019-0310
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：575 / 578
页数：4
相关论文
共 50 条
  • [1] Pneumococcal immunization with conjugate vaccines: are 10-valent and 13-valent vaccines similar?
    Esposito, Susanna
    Principi, Nicola
    [J]. FUTURE MICROBIOLOGY, 2019, 14 (11) : 921 - 923
  • [2] Comparing the Impact of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease
    Theilacker, Christian
    Hilton, Betsy
    Jiang, Qin
    Gessner, Bradford D.
    [J]. CLINICAL INFECTIOUS DISEASES, 2018, 66 (10) : 1641 - 1642
  • [3] Comparing the Impact of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease Reply
    Naucler, Pontus
    Galanis, Ilias
    Morfeldt, Eva
    Darenberg, Jessica
    Ortqvist, Ake
    Henriques-Normark, Birgitta
    [J]. CLINICAL INFECTIOUS DISEASES, 2018, 66 (10) : 1642 - 1643
  • [4] The impact of 10-valent and 13-valent pneumococcal conjugate vaccines on serotype 19A invasive pneumococcal disease
    Principi, Nicola
    Esposito, Susanna
    [J]. EXPERT REVIEW OF VACCINES, 2015, 14 (10) : 1359 - 1366
  • [5] CLINICAL AND ECONOMIC BENEFITS OF NATIONAL IMMUNIZATION WITH THE 13-VALENT COMPARED TO 7-AND 10-VALENT PNEUMOCOCCAL CONJUGATE VACCINES IN GREECE
    Papanicolaou, S.
    Kontodimas, S.
    Syriopoulou, V
    Tsolia, M.
    Theodoridou, M.
    Strutton, D. R.
    Hwang, S.
    Tzanakaki, G.
    Kremastinou, J.
    Earnshaw, S. R.
    Farkouh, R.
    Karokis, A.
    Konstantopoulos, A.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A423 - A424
  • [6] Serotype Replacement after Introduction of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccines in 10 Countries, Europe
    Hanquet, Germaine
    Krizova, Pavla
    Dalby, Tina
    Ladhani, Shamez N.
    Nuorti, J. Pekka
    Danis, Kostas
    Mereckiene, Jolita
    Knol, Mirjam J.
    Winje, Brita A.
    Ciruela, Pilar
    de Miguel, Sara
    Eugenia Portillo, Maria
    MacDonald, Laura
    Morfeldt, Eva
    Kozakova, Jana
    Valentiner-Branth, Palle
    Fry, Norman K.
    Rinta-Kokko, Hanna
    Varon, Emmanuelle
    Corcoran, Mary
    van der Ende, Arie
    Vestrheim, Didrik F.
    Munoz-Almagro, Carmen
    Sanz, Juan-Carlos
    Castilla, Jesus
    Smith, Andrew
    Henriques-Normark, Birgitta
    Colzani, Edoardo
    Pastore-Celentano, Lucia
    Savulescu, Camelia
    [J]. EMERGING INFECTIOUS DISEASES, 2022, 28 (01) : 127 - 138
  • [7] A COMPARISON OF THE COST-EFFECTIVENESS OF THE 13-VALENT (PCV13) AND 10-VALENT PNEUMOCOCCAL CONJUGATE VACCINES IN THE UK
    Patel, R.
    Stoykova, B.
    Lloyd, A. C.
    Willingham, J.
    Hollingsworth, R.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A428 - A428
  • [8] Estimating the Public Health and Economic Impact of Introducing the 13-Valent Pneumococcal Conjugate Vaccine or 10-Valent Pneumococcal Conjugate Vaccines into State Immunization Programs in India
    Ghia, Canna J.
    Horn, Emily K.
    Rambhad, Gautam
    Perdrizet, Johnna
    Chitale, Ramaa
    Wasserman, Matt D.
    [J]. INFECTIOUS DISEASES AND THERAPY, 2021, 10 (04) : 2271 - 2288
  • [9] Cost-effectiveness of 2 + 1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in Canada
    Stephanie R Earnshaw
    Cheryl L McDade
    Giovanni Zanotti
    Raymond A Farkouh
    David Strutton
    [J]. BMC Infectious Diseases, 12
  • [10] Cost-effectiveness of 2+1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in Canada
    Earnshaw, Stephanie R.
    McDade, Cheryl L.
    Zanotti, Giovanni
    Farkouh, Raymond A.
    Strutton, David
    [J]. BMC INFECTIOUS DISEASES, 2012, 12
12345